A

Apellis Pharmaceuticals
D

APLS

33.220
USD
0.09
(0.27%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-16
حجم السوق
4,132,336,025
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    0.01000
    (0.31%)
    3.20000 USD
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    A
    ANAB
    -0.420
    (-2.80%)
    14.570 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    A
    ATNX
    -0.34000
    (-19.65%)
    1.43000 USD
    BGNE
    BGNE
    1.300
    (0.74%)
    176.450 USD
    BIIB
    BIIB
    -0.780
    (-0.53%)
    146.590 USD
    BMY
    BMY
    0.990
    (1.76%)
    57.280 USD
    C
    CRBP
    -0.370
    (-2.78%)
    12.960 USD
    E
    EXEL
    -0.390
    (-1.16%)
    33.280 USD
    GE
    GE
    3.740
    (2.27%)
    168.530 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    I
    INCY
    1.910
    (2.85%)
    68.910 USD
    المزيد
الأخبار

العنوان: Apellis Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.